NCT04837651 Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Natalizumab Status COMPLETED Phase N/A
NCT04818970 Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients Status COMPLETED Phase NA
NCT04818229 A Study to Investigate the Effects of CBP-307 on the Heart Rate-corrected QT Interval (QTc) in Healthy Subjects Status COMPLETED Phase PHASE1
NCT04806620 Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research Status RECRUITING Phase N/A
NCT04805099 Checkpoint Inhibitors in Patients With Cancer and Underlying Autoimmune Disease Status COMPLETED Phase N/A
NCT04789993 Additional Autoimmune Diseases With Type 1 Diabetes in Pediatrics at Diabetes Diagnosis and During Follow-up Status UNKNOWN Phase N/A
NCT04786821 Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple Sclerosis Status COMPLETED Phase NA
NCT04691232 Autologous Ex Vivo Expanded Regulatory T Cells in Ulcerative Colitis Status COMPLETED Phase PHASE1
NCT04684602 Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions Status RECRUITING Phase PHASE1/PHASE2
NCT04665232 Immunomodulatory Effects of Subcutaneous Progesterone in Patients Affected by Autoimmune Diseases Status COMPLETED Phase N/A
NCT04663204 A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy Status RECRUITING Phase PHASE2
NCT04561557 Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System Status RECRUITING Phase EARLY_PHASE1
NCT04353609 Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases Status COMPLETED Phase N/A
NCT04298749 Safety and Tolerability of GX-P1 in Healthy Male Volunteers Status COMPLETED Phase PHASE1